EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The CXCR3 antagonist NBI-74330 alleviates neuroimmune dysfunction by lowering pro-inflammatory mediator signaling in CD45+ cells of BTBR T+ Itpr3tf/J mice

Haneen A. Al-Mazroua, Hussain N. Alhamami, Saleh A. Bakheet, Mushtaq A. Ansari, Ahmed Nadeem, Sabry M. Attia, Abdullah S. Alhamed, Abdulaziz M. S. Alsaad, Hatun A. Alomar, Alaa A. Alanteet, Sheikh F. Ahmad

Frontiers in Psychiatry · 13.11.2026 · 17

DOI: 10.3389/fpsyt.2026.1971064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 13.11.2026. Verfasst von Haneen A. Al-Mazroua und 10 weiteren Autor:innen. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects social interaction and communication and is often accompanied by stereotyped behaviors. This study examined the effects of the CXCR3 antagonist NBI-74330 on BTBR T+ Itpr3tf/J (BTBR), an autistic mouse model. Recent research suggests that NBI-74330, a CXCR3 antagonist, could have therapeutic benefits in inflammatory and neurodegenerative diseases.

Methods

We examined NBI-74330's effects on social behavior, self-grooming, and marble burying in BTBR mice. We also evaluated its impact on IFN-γ, T-bet, IL-17A, RORγt, STAT3, IL-22, and AhR levels in CD45 + spleen cells. We measured mRNA levels of these inflammatory mediators in brain tissue.

Results

Results showed that NBI-74330 significantly improved social interactions and decreased self-grooming and marble-burying behaviors in BTBR mice without affecting arousal, anxiety, or locomotion. Immunological analysis showed marked reductions in CD45 + IFN-γ + , CD45 + T-bet + , CD45 + IL-17A + , CD45 + RORγt + , CD45 + STAT3 + , CD45 + IL-22 + , and CD45 + AhR + cells. NBI-74330-treated BTBR mice exhibited lower mRNA levels of these proinflammatory mediators.

Discussion

These findings suggest that NBI-74330 can reduce behavioral abnormalities and immune dysregulation in BTBR mice. To our knowledge, this is the first evidence supporting the potential of the CXCR3 antagonist NBI-74330 as a therapeutic option for autism-like symptoms.

Zitieren

APA

Al-Mazroua, H. A., Alhamami, H. N., Bakheet, S. A., Ansari, M. A., Nadeem, A., Attia, S. M., Alhamed, A. S., Alsaad, A. M. S., Alomar, H. A., Alanteet, A. A., & Ahmad, S. F. (2026). The CXCR3 antagonist NBI-74330 alleviates neuroimmune dysfunction by lowering pro-inflammatory mediator signaling in CD45+ cells of BTBR T+ Itpr3tf/J mice. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1971064

Vancouver

Al-Mazroua HA, Alhamami HN, Bakheet SA, Ansari MA, Nadeem A, Attia SM, et al. The CXCR3 antagonist NBI-74330 alleviates neuroimmune dysfunction by lowering pro-inflammatory mediator signaling in CD45+ cells of BTBR T+ Itpr3tf/J mice. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1971064

BibTeX
@article{AlMazroua2026,
  author = {Al-Mazroua, Haneen A. and Alhamami, Hussain N. and Bakheet, Saleh A. and Ansari, Mushtaq A. and Nadeem, Ahmed and Attia, Sabry M. and Alhamed, Abdullah S. and Alsaad, Abdulaziz M. S. and Alomar, Hatun A. and Alanteet, Alaa A. and Ahmad, Sheikh F.},
  title = {The CXCR3 antagonist NBI-74330 alleviates neuroimmune dysfunction by lowering pro-inflammatory mediator signaling in CD45+ cells of BTBR T+ Itpr3tf/J mice},
  journal = {Frontiers in Psychiatry},
  year = {2026},
  volume = {17},
  doi = {10.3389/fpsyt.2026.1971064}
}
Kostenlos starten →